Veer Chahwala
Vascular Surgery · Marietta, GANPI 1801114335
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (49.5%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 37 manufacturers reported payments, led by Penumbra, Inc. at 57.9% of the total. Reporting peaked in 2024 at $9,244 and has fallen 53.9% since, to $4,263 in 2025.
Across 210 payments — averaging $97.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Penumbra, Inc.$12K
- W. L. Gore & Associates, Inc.$2K
- Lemaitre Vascular, Inc.$1K
- Boston Scientific$786
- Johnson & Johnson$720
- Imperative Care, Inc$471
- plus $4K from 31 others
What the payments were for
- Consulting fees$4002%
- Speaking & faculty fees$2,40012%
- Travel & lodging$7,54337%
- Food & beverage$10,17349%
- Education$460%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Penumbra, Inc. | 44 | $11,904 |
| W. L. Gore & Associates, Inc. | 23 | $1,980 |
| Lemaitre Vascular, Inc. | 4 | $1,172 |
| Boston Scientific | 30 | $786 |
| Johnson & Johnson(2 entities) | 25 | $720 |
| Imperative Care, Inc | 17 | $471 |
| Merit Medical Systems Inc | 1 | $400 |
| Silk Road Medical, Inc. | 4 | $325 |
| Abbott | 5 | $305 |
| Medtronic(2 entities) | 6 | $263 |
| Cardiovascular Systems Inc. | 2 | $258 |
| Shockwave Medical, Inc | 4 | $254 |
| Bard Peripheral Vascular, Inc. | 2 | $231 |
| Terumo Medical Corporation | 2 | $203 |
| Angiodynamics, Inc. | 9 | $200 |
| Cook Medical LLC | 3 | $185 |
| Mozarc Medical US LLC | 4 | $144 |
| Argon Medical Devices, Inc. | 1 | $141 |
| Lifenet Health | 1 | $108 |
| Philips North America LLC | 2 | $83 |
| Smith+Nephew | 2 | $65 |
| Novartis | 2 | $45 |
| Inari Medical, Inc. | 1 | $37 |
| Medistim USA, Inc. | 1 | $33 |
| Pfizer | 2 | $30 |
| Cvrx, Inc. | 1 | $28 |
| Solventum Corporation | 2 | $28 |
| Boehringer Ingelheim | 1 | $22 |
| Endologix LLC | 1 | $21 |
| Acera Surgical, Inc. | 1 | $19 |
| Cordis US CORP. | 1 | $17 |
| Convatec Inc. | 1 | $16 |
| Truvic Medical, Inc. | 1 | $16 |
| Baxter Healthcare | 1 | $15 |
| Reprise Biomedical, Inc. | 1 | $13 |
| Cardiva Medical, Inc. | 1 | $12 |
| Integra Lifesciences Corporation | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo System$10,631
- VALVULOTOM$1,147
- GORE VIABAHN VBX Balloon Expandable Endo$804
- Penumbra System$501
- ENROUTE Transcarotid Neuroprotection System$470
- GORE TAG Thoracic Branch Endoprosthesis$194
- GORE VIABAHN Endoprosthesis$182
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$177
- ENROUTE Transcarotid Stent$151
- ENROUTE Transcarotid Stent System$148
- ENHANCE Transcarotid Peripheral Access Kit$148
- ENROUTE 0.014 Guidewire$148
- Diamondback Peripheral$146
- VISTASEAL$144
- SURGICEL NU-KNIT$144
- EVARREST$144
- RotarexS 6 F x 135 cm$142
- Clot Management$141
- GORE VIABAHN Endoprosthesis with Heparin$140
- JETi Peripheral Catheter$130
How this compares
$20,562 in reported general payments places this provider in the 80th percentile of 176 vascular surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 54 | $30,864 |
| XareltoRivaroxaban | 11 | $6,236 |
| ClopidogrelClopidogrel Bisulfate | 74 | $565 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 26 | $122 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $30 | $30,86454 claims |
| Johnson & JohnsonXarelto | $720 | $6,23611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 176 vascular surgery providers in Georgia.
Other vascular surgery in Marietta
- Alykhan LalaniMarietta$64K
- Julie DukeMarietta$19K
- Arun ChervuMarietta$13K
- Gary JacobsonMarietta$13K
- Emily LagergrenMarietta$11K
- Jeffrey SteinMarietta$10K
- Siddharth PatelAtlanta$303K
- Juan AyerdiColumbus$130K
- Albert RichardsonThomasville$103K
- Walaya Methodius-RayfordAtlanta$79K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.